Oellerich, M., Schütz, E., Kanzow, P., Schmitz, J., Beck, J., Kollmar, O., et al. (2014) Use of Graft-Derived Cell-Free DNA as an Organ Integrity Biomarker to Reexamine Effective Tacrolimus trough Concentrations after Liver Transplantation. Therapeutic Drug Monitoring, 36, 136-140.
https://doi.org/10.1097/FTD.0000000000000044

has been cited by the following article:

• TITLE: A Novel Next-Generation Sequencing Approach without Donor-Derived Material for Acute Rejection and Infection Monitoring in Solid Organ Transplantation

  AUTHORS: Bing Wei, Liuhong Zeng, Di Shao, Chunting Zheng, Qing Yang, Jibin Zhang, Dong Xiao, Qiuhua Deng, Yongping Lin, Danxia Huang, Liping Liu, Xin Xu, Wenhua Liang, Chunrong Ju, Jian Wang, Karsten Kristiansen, Jianxing He, Mingzhi Ye

  KEYWORDS: Cell-Free DNA, Genome Transplant Dynamics, Acute Rejection, Transplant, Infection

  JOURNAL NAME: Journal of Cancer Therapy, Vol.9 No.9, September 5, 2018

  ABSTRACT: Background: Donor-derived cell free DNA (ddcf DNA) has been reported as a universal noninvasive biomarker for rejection monitoring in heart, kidney, liver, and lung transplantation. Current approaches based on next-generation sequencing for quantification of ddcf DNA, although promising, may be restricted by the requirement for donor material, as donor samples may not be available. Methods: We proposed a novel next-generation sequencing approach without donor-derived material and compared the non-donor-derived approach and the donor-derived approach using simulation testing and 69 clinical specimens. We also evaluated the performance for acute rejection and infection monitoring in lung transplantation. Results: The non-donor-derived approach reached similar efficacy as the donor-derived approach with a significant linear correlation of R2 = 0.98. Subsequent validation in clinical specimens demonstrated significant difference between the acute rejection group (4.83% ± 2.11%, mean ± SD) and the non-rejection group (1.61% ± 0.63%, mean ± SD) (P ’s t test). With the cut-off value of 2.999, our approach had 90.48% sensitivity (95% CI, 69.62% - 98.83%), 100% specificity (95% CI, 91.59% - 100%), and AUC 0.9266 (95% CI, 0.8277 - 1.026). The test also had the ability to simultaneously detect infectious agents, especially cytomegalovirus, as compared with the clinical test. Conclusion: The proposed approach without donor-derived material could potentially be used to monitor acute rejection and infection in lung transplantation and may be applied to other types of solid organ transplantation.